Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
Members of the family who own Purdue Pharma, the maker of oxycodone hydrochloride (OxyContin), and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the ...
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.
The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...
For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug Administration approved the opioid OxyContin for the treatment of chronic pain.
Kaitlyn Dever has quickly emerged as one of the standout stars of her generation, establishing herself as one of the most ...
M embers of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, New York ...
Purdue Pharma and the family that owns the company have agreed to pay up to $7.4 billion to settle lawsuits filed over the toll OxyContin has taken. The amount agreed upon is more than what was ...